- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER2 Positive Breast in Germany
Total 903 results
-
University Hospital TuebingenCharite University, Berlin, Germany; Robert Bosch Hospital StuttgartRecruitingBreast Cancer Patients Treated With Aromatase InhibitorsGermany
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
Fondazione MichelangeloCompletedInvasive Ductal Breast CarcinomaSpain, Ireland, Italy, Taiwan, Germany, Austria, Russian Federation
-
University Hospital TuebingenRecruitingAdvanced/Metastatic Breast Cancer | Breast Cancer (Early Breast Cancer)Germany
-
Eli Lilly and CompanyCompletedBreast CancerUnited States, Belgium, Spain, Germany, United Kingdom, France
-
Heinrich-Heine University, DuesseldorfUnknown
-
Breast International GroupJules Bordet Institute; Frontier Science & Technology Research Foundation,...RecruitingMetastatic Breast CancerBelgium, Spain, Portugal, United Kingdom, Italy, Germany, Iceland, Luxembourg, Sweden, Switzerland
-
Michael HoelscherGerman Federal Ministry of Education and Research; German Center for Infection... and other collaboratorsCompletedLung Diseases | Bacterial Infections | Mycobacterium Infections | Tuberculosis | Tuberculosis, PulmonaryGermany
-
NovartisCompleted
-
Novartis PharmaceuticalsActive, not recruitingALK Positive MalignanciesChina, United States, Italy, Taiwan, Australia, Belgium, Germany, Spain, Czechia, Japan, Russian Federation, Korea, Republic of, Hong Kong, France, Lebanon, Malaysia, Brazil, Poland, Bulgaria, Colombia, Singapore
-
Novartis PharmaceuticalsTerminatedBreast CancerFrance, Canada, United Kingdom, Germany, Italy, United States
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)Germany
-
Royal Brompton & Harefield NHS Foundation TrustHeidelberg University; Chelsea and Westminster NHS Foundation TrustWithdrawnLymphoma | Carcinoma | Sarcoidosis | Mediastinal Lymphadenopathy | Hilar Lymphadenopathy | Mycobacterial DiseaseUnited Kingdom, Germany
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited Kingdom, Germany
-
Astellas Pharma IncCompletedBreast CancerUnited States, Ireland, Belgium, Czech Republic, Germany, Poland, Russian Federation, United Kingdom
-
Dr. Frank BehrensPfizerRecruiting
-
Prof Dr Frank ButtgereitRecruitingOsteoporosis | Inflammatory RheumatismGermany
-
SuperSonic ImagineCompletedBreast NeoplasmsFrance, Germany, United States, Italy, United Kingdom
-
Valneva Austria GmbHCompletedClostridium DifficileGermany, United States
-
Fondazione MichelangeloHoffmann-La RocheActive, not recruitingInvasive Breast CancerSpain, Italy, Germany, Austria
-
Cantargia ABActive, not recruitingColorectal Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreatic Ductal AdenocarcinomaAustria, Denmark, Germany, Belgium, Spain, Latvia, Netherlands, Lithuania, Estonia, Sweden, Norway
-
Novartis PharmaceuticalsCompletedStomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 ProteinTaiwan, Switzerland, Korea, Republic of, Germany, United States, Japan
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Leukemia, Lymphoblastic, Acute, Philadelphia-positiveNetherlands, United States, Italy, Argentina, Austria, Brazil, Canada, Germany, Peru, United Kingdom, France, Korea, Republic of, Sweden, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzerland
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerUnited States, France, Canada, Brazil, Poland, Germany, Portugal, Spain, Sweden, Slovakia, Czech Republic, Uruguay, Argentina, Egypt, Hungary, Israel, South Africa, Austria, Greece, United Kingdom
-
Hegau-Bodensee-Klinikum SingenDepartment of Health and Human ServicesActive, not recruitingSARS-CoV-2 Positive PatientsGermany
-
ETOP IBCSG Partners FoundationHoffmann-La RocheRecruitingBreast CancerIreland, Italy, Germany, Spain, Hungary, France, Sweden, Switzerland
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedBreast NeoplasmsSweden, United States, United Kingdom, Germany, Spain, Australia, Israel, Canada
-
University Hospital TuebingenCompleted
-
Novartis PharmaceuticalsCompleted
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Krebsforschung Schweiz, Bern, Switzerland; Rising Tide FoundationRecruitingLymphedema, Breast CancerSpain, Switzerland, United States, Germany, Argentina, Austria, Belgium, Brazil, Canada, Greece, Italy, Netherlands, Romania, Sweden
-
European Organisation for Research and Treatment...Pfizer; ETOP IBCSG Partners Foundation; UNICANCER; Breast International Group; SOLTI... and other collaboratorsActive, not recruitingBreast Cancer Stage II | Breast Cancer Stage IIISpain, France, Italy, Belgium, Jordan, Poland, Germany, United Kingdom, Portugal
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, United Kingdom, Germany, Austria, India
-
European Society for Blood and Marrow TransplantationAmgenWithdrawnChronic Myeloid Leukemia | Myelodysplastic Syndrome | Acute Leukaemia | Non-Hodgkin's Lymphoma or Hodgkin's Disease | OsteomyelofibrosisGermany
-
Universitätsklinikum Hamburg-EppendorfRecruitingCoronary Disease | Diabetes Mellitus, Type 2 | Breast Neoplasms | Diabetes Mellitus, Type 1 | Pulmonary Disease, Chronic Obstructive | Asthma | Comorbidities and Coexisting ConditionsGermany
-
University Hospital TuebingenRecruitingBreast Cancer | Head and Neck Cancer | Esophageal Cancer | Rectal Cancer | Prostate Cancer | Liver Cancer | OligometastasisGermany
-
Genentech, Inc.Hoffmann-La RocheCompletedBreast CancerUnited States, Belgium, France, Germany, United Kingdom, Spain
-
University Medicine GreifswaldUniversity of GreifswaldRecruitingBreast Cancer | Cognitive ImpairmentGermany
-
Novartis PharmaceuticalsCompleted
-
Hoffmann-La RocheGilead Sciences; Seagen Inc.RecruitingBreast CancerKorea, Republic of, Spain, United States, Israel, United Kingdom, France, Australia, Germany
-
Heinrich-Heine University, DuesseldorfCompletedBreast Cancer | Cardiotoxicity | Myocardial DamageGermany
-
MedSIRActive, not recruitingBreast CancerSpain, Italy, France, United Kingdom, Germany, Portugal, Belgium
-
GlaxoSmithKlineTerminatedNeoplasms, BreastBelgium, United Kingdom, United States, Germany, Russian Federation, Italy
-
Hoffmann-La RocheCompletedBreast CancerSpain, Russian Federation, Austria, Italy, Germany, Portugal
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, ChronicUnited States, Germany
-
University Hospital Schleswig-HolsteinUniversity of LuebeckActive, not recruitingEarly-Stage Breast CarcinomaGermany
-
Hoffmann-La RocheCompleted
-
University Hospital TuebingenUnknownMetastatic Breast CancerGermany
-
Seagen Inc.Active, not recruitingUrologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Carcinoma, Non-Small-Cell Lung | Biliary Tract Neoplasms | HER2 Mutations Breast NeoplasmsUnited States, United Kingdom, Spain, Korea, Republic of, Italy, Belgium, Germany, Japan, Netherlands, Poland
-
PfizerCompletedBreast NeoplasmsNetherlands, United States, United Kingdom, Germany, Italy